BioNtech's pre-market rise by more than 3%, with Q3 revenue greatly exceeding expectations.

BioNtech SE pre-market is up more than 3%. On the news front, the company announced a revenue of 1.52 billion euros for Q3 2025, exceeding market expectations of 960 million euros, a year-on-year increase of 22.08%.